Overview

Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization

Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical results of anti-VEGF intra-vitreal injections (IVT) in CNV secondary
Phase:
Phase 4
Details
Lead Sponsor:
Instituto de Olhos de Goiania
Treatments:
Aflibercept